We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-2.92%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$1.93B
AUM Growth
-$130M
Cap. Flow
-$54.2M
Cap. Flow %
-2.81%
Top 10 Hldgs %
30.03%
Holding
2,489
New
31
Increased
1,105
Reduced
525
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Healthcare 11.48%
3 Financials 10.72%
4 Consumer Discretionary 9.28%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALT icon
2351
Altimmune
ALT
$560M
$7.09K ﹤0.01%
2,727
RRGB icon
2352
Red Robin
RRGB
$184M
$7.05K ﹤0.01%
877
DHX icon
2353
DHI Group
DHX
$171M
$7.02K ﹤0.01%
2,295
STKS icon
2354
The ONE Group
STKS
$56.8M
$7.02K ﹤0.01%
1,276
TELA icon
2355
TELA Bio
TELA
$32.5M
$7.02K ﹤0.01%
877
SEER icon
2356
Seer Inc
SEER
$117M
$7.01K ﹤0.01%
3,172
WLFC icon
2357
Willis Lease Finance
WLFC
$1.16B
$6.98K ﹤0.01%
495
+27
+6% +$381
NGVC icon
2358
Vitamin Cottage Natural Grocers
NGVC
$643M
$6.97K ﹤0.01%
+540
New +$6.88K
EVI icon
2359
EVI Industries
EVI
$204M
$6.92K ﹤0.01%
+279
New +$7.04K
MLYS icon
2360
Mineralys Therapeutics
MLYS
$2.35B
$6.91K ﹤0.01%
727
SMTI icon
2361
Sanara MedTech
SMTI
$315M
$6.91K ﹤0.01%
222
BIRD icon
2362
Smartbird Inc
BIRD
$29.2M
$6.88K ﹤0.01%
+310
New +$8.35K
BH icon
2363
Biglari Holdings Class B
BH
$1.24B
$6.81K ﹤0.01%
41
INGN icon
2364
Inogen
INGN
$154M
$6.76K ﹤0.01%
1,296
MEC icon
2365
Mayville Engineering Co
MEC
$598M
$6.67K ﹤0.01%
608
KLRS
2366
Kalaris Therapeutics
KLRS
$93.8M
$6.66K ﹤0.01%
135
+59
+78% +$4.02K
TNYA icon
2367
Tenaya Therapeutics
TNYA
$169M
$6.65K ﹤0.01%
2,607
MRSN
2368
DELISTED
Mersana Therapeutics
MRSN
$6.49K ﹤0.01%
204
FHTX icon
2369
Foghorn Therapeutics
FHTX
$390M
$6.47K ﹤0.01%
1,295
RCKY icon
2370
Rocky Brands
RCKY
$353M
$6.45K ﹤0.01%
439
CDXS icon
2371
Codexis
CDXS
$177M
$6.41K ﹤0.01%
3,389
CLPT icon
2372
ClearPoint Neuro
CLPT
$465M
$6.36K ﹤0.01%
1,270
HRTX icon
2373
Heron Therapeutics
HRTX
$63.9M
$6.35K ﹤0.01%
6,161
+468
+8% +$666
XOMA
2374
DELISTED
Xoma
XOMA
$6.31K ﹤0.01%
448
+42
+10% +$659
TUSK icon
2375
Mammoth Energy Services
TUSK
$158M
$6.25K ﹤0.01%
+1,348
New +$6.56K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2023 Portfolio in Review

As of Q3 2023, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $1.93B, down 6.3% from $2.06B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.9%. Metropolitan Life Insurance Company (MetLife) opened 31 new positions and exited 91, leaving the 2,489-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2023 buy was Vanguard Long-Term Corporate Bond ETF: 296,480 shares worth $21.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q3 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $10.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited State Street SPDR Portfolio Long Term Corporate Bond ETF in Q3 2023, selling an estimated $23.3M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $1.93B portfolio in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 31 new positions and closed 91 in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 6.3% quarter-over-quarter to $1.93B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.